Profund Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-10,005
Closed -$118K – 1229
2025
Q4
$118K Buy
+10,005
New +$108K ﹤0.01% 1223
2022
Q3
– Sell
-11,592
Closed -$94K – 987
2022
Q2
$94K Sell
11,592
-2,814
-20% -$26.9K 0.01% 978
2022
Q1
$175K Buy
14,406
+647
+5% +$13.6K 0.01% 1290
2021
Q4
$469K Buy
13,759
+554
+4% +$21.7K 0.02% 646
2021
Q3
$637K Buy
13,205
+485
+4% +$22.5K 0.02% 522
2021
Q2
$574K Buy
12,720
+594
+5% +$26.3K 0.02% 594
2021
Q1
$585K Sell
12,126
-780
-6% -$40.6K 0.02% 505
2020
Q4
$695K Buy
12,906
+3,810
+42% +$172K 0.03% 419
2020
Q3
$336K Sell
9,096
-732
-7% -$27.2K 0.02% 615
2020
Q2
$304K Buy
+9,828
New +$272K 0.02% 594
2020
Q1
– Sell
-10,422
Closed -$305K – 1030
2019
Q4
$305K Buy
10,422
+186
+2% +$4.43K 0.01% 912
2019
Q3
$196K Buy
10,236
+343
+3% +$8.05K 0.01% 1179
2019
Q2
$217K Buy
+9,893
New +$217K 0.01% 1100

Other funds holding NEO

Profund Advisors's NEO Position: Q1 2026 in Review

Profund Advisors sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 10,005 shares — an estimated $118K sold.

Profund Advisors first reported a position in NEO in Q2 2019 and held it in 13 quarters. The position peaked at $695K in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Profund Advisors reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Profund Advisors sold 10,005 NeoGenomics shares in Q1 2026, an estimated $118K.
  • Profund Advisors first reported a position in NeoGenomics in Q2 2019 and held it in 13 quarters.
  • Profund Advisors's NeoGenomics position peaked at $695K in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.